Brain Disease Research Co. Raises $45M In Funding Round
A pharmaceutical research and development group looking for treatments for brain diseases said Tuesday it closed on $45 million in a funding round that included the investment arm of Takeda Pharmaceuticals....To view the full article, register now.
Already a subscriber? Click here to view full article